Reece Marillier

551 total citations
19 papers, 274 citations indexed

About

Reece Marillier is a scholar working on Physiology, Immunology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Reece Marillier has authored 19 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 7 papers in Immunology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Reece Marillier's work include Adenosine and Purinergic Signaling (7 papers), Parasites and Host Interactions (5 papers) and Research on Leishmaniasis Studies (5 papers). Reece Marillier is often cited by papers focused on Adenosine and Purinergic Signaling (7 papers), Parasites and Host Interactions (5 papers) and Research on Leishmaniasis Studies (5 papers). Reece Marillier collaborates with scholars based in South Africa, Belgium and United States. Reece Marillier's co-authors include Frank Brombacher, Mosiuoa Leeto, Benjamin G Dewals, William Horsnell, Anita Schwegmann, Lizette Fick, J. Claire Hoving, Jacques Van Snick, Catherine Uyttenhove and Elizabeth M. Smith and has published in prestigious journals such as Blood, Nature Immunology and Cancer Research.

In The Last Decade

Reece Marillier

18 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Reece Marillier South Africa	9	143	100	50	37	35	19	274
Jia Xianli United States	7	197 1.4×	100 1.0×	135 2.7×	23 0.6×	29 0.8×	7	353
Cristian R. Falcón Argentina	10	138 1.0×	131 1.3×	35 0.7×	38 1.0×	43 1.2×	13	311
Faisal Wahid United Kingdom	7	179 1.3×	32 0.3×	141 2.8×	59 1.6×	16 0.5×	11	407
David Carey United States	9	43 0.3×	200 2.0×	132 2.6×	57 1.5×	122 3.5×	12	380
Jiajia Chen China	7	159 1.1×	57 0.6×	27 0.5×	42 1.1×	17 0.5×	16	278
Megan S. F. Soon Australia	14	201 1.4×	27 0.3×	165 3.3×	29 0.8×	9 0.3×	21	342
Virginie Gonzalez France	11	80 0.6×	165 1.6×	62 1.2×	6 0.2×	22 0.6×	16	363
C A Bogowitz United States	5	154 1.1×	96 1.0×	12 0.2×	30 0.8×	66 1.9×	8	410
Eda Patricia Tenorio Mexico	11	168 1.2×	108 1.1×	17 0.3×	41 1.1×	12 0.3×	18	335

Countries citing papers authored by Reece Marillier

Since Specialization

Citations

This map shows the geographic impact of Reece Marillier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reece Marillier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reece Marillier more than expected).

Fields of papers citing papers by Reece Marillier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reece Marillier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reece Marillier. The network helps show where Reece Marillier may publish in the future.

Co-authorship network of co-authors of Reece Marillier

This figure shows the co-authorship network connecting the top 25 collaborators of Reece Marillier. A scholar is included among the top collaborators of Reece Marillier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reece Marillier. Reece Marillier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Janss, Thibaut, Virginie Rabolli, Iain Welsby, et al.. (2025). Abstract 3136: EOS-215, a first-in-class TREM2 antagonist, designed to reprogram the tumor microenvironment and overcome resistance. Cancer Research. 85(8_Supplement_1). 3136–3136.

Sanders, Theodore J., Christopher S. Nabel, Margreet Brouwer, et al.. (2025). Inhibition of ENT1 relieves intracellular adenosine-mediated T cell suppression in cancer. Nature Immunology. 26(6). 854–865. 10 indexed citations

Sanders, Theodore J., Christopher S. Nabel, Margreet Brouwer, et al.. (2024). Abstract 734: Inhibition of equilibrative nucleoside transporter 1 relieves intracellular adenosine-mediated immune suppression. Cancer Research. 84(6_Supplement). 734–734. 1 indexed citations

McCann, Patrick J., Wendy Mao, Matthew G. Chaimowitz, et al.. (2023). Abstract B032: Combined A2AR and PARP inhibition in homologous recombination deficient (HRD) castrate-resistant prostate cancer (CRPC). Cancer Research. 83(11_Supplement). B032–B032. 1 indexed citations

Ait-Belkacem, Rima, et al.. (2019). Target exposure and pharmacodynamics study of the indoleamine 2,3-dioxygenase-1 (IDO-1) inhibitor epacadostat in the CT26 mouse tumor model. Journal of Pharmaceutical and Biomedical Analysis. 170. 220–227. 8 indexed citations

Jamart, Diane, Paola Basilico, Chiara Martinoli, et al.. (2019). Abstract 4147: EOS100850, an A2Areceptor antagonist with prolonged pharmacodynamic activity, mediates the generation ofspecific durable immune responses in a murine breast cancer model. Cancer Research. 79(13_Supplement). 4147–4147. 1 indexed citations

Houthuys, Erica, Paola Basilico, Margreet Brouwer, et al.. (2019). Abstract 3278: EOS100850 potently restores adenosine A2Areceptor-dependent suppression of T cell function in the adenosine rich tumor microenvironment. Cancer Research. 79(13_Supplement). 3278–3278. 1 indexed citations

Houthuys, Erica, Paola Basilico, Margreet Brouwer, et al.. (2019). Abstract 3261: EOS100850, a non-brain penetrant highly selective A2Areceptor antagonist, uniquely maintains high potency within the adenosine rich tumor microenvironment. Cancer Research. 79(13_Supplement). 3261–3261. 6 indexed citations

Marillier, Reece, et al.. (2018). The TLR7 ligand R848 prevents mouse graft-versus-host disease and cooperates with anti-interleukin-27 antibody for maximal protection and regulatory T-cell upregulation. Haematologica. 104(2). 392–402. 8 indexed citations

10.

Marillier, Reece, Catherine Uyttenhove, Nicolas Dauguet, et al.. (2017). Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells. Immunity Inflammation and Disease. 5(2). 200–213. 4 indexed citations

11.

Houthuys, Erica, Margreet Brouwer, Reece Marillier, et al.. (2017). Abstract 1683: A novel adenosine A2A receptor antagonist optimized for high potency in adenosine-rich tumor microenvironment boosts antitumor immunity. Cancer Research. 77(13_Supplement). 1683–1683. 5 indexed citations

12.

Belle, Ludovic, Richard Komorowski, Daniel Eastwood, et al.. (2016). Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression. Blood. 128(16). 2068–2082. 31 indexed citations

13.

Marillier, Reece, Catherine Uyttenhove, Stanislas Goriely, Étienne Marbaix, & Jacques Van Snick. (2014). IL‐27p28 is essential for parent‐to‐F1 acute graft‐versus‐host disease. European Journal of Immunology. 44(7). 2064–2073. 10 indexed citations

14.

Uyttenhove, Catherine, Reece Marillier, Fabienne Tacchini‐Cottier, et al.. (2011). Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 inL. majorinfection. Journal of Leukocyte Biology. 89(6). 1001–1007. 29 indexed citations

15.

Dewals, Benjamin G, Reece Marillier, J. Claire Hoving, et al.. (2010). IL-4Rα-Independent Expression of Mannose Receptor and Ym1 by Macrophages Depends on their IL-10 Responsiveness. PLoS neglected tropical diseases. 4(5). e689–e689. 42 indexed citations

16.

Marillier, Reece, Benjamin G Dewals, Mosiuoa Leeto, et al.. (2010). IL-4Rα-responsive smooth muscle cells increase intestinal hypercontractility and contribute to resistance during acute Schistosomiasis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 298(6). G943–G951. 19 indexed citations

17.

Dewals, Benjamin G, J. Claire Hoving, Mosiuoa Leeto, et al.. (2009). IL-4Rα Responsiveness of Non-CD4 T Cells Contributes to Resistance in Schistosoma mansoni Infection in Pan-T Cell-Specific IL-4Rα-Deficient Mice. American Journal Of Pathology. 175(2). 706–716. 26 indexed citations

18.

Marillier, Reece, Elizabeth M. Smith, Lizette Fick, et al.. (2008). IL-4/IL-13 independent goblet cell hyperplasia in experimental helminth infections. BMC Immunology. 9(1). 11–11. 49 indexed citations

19.

Leeto, Mosiuoa, De’Broski R. Herbert, Reece Marillier, et al.. (2006). TH1-Dominant Granulomatous Pathology Does Not Inhibit Fibrosis or Cause Lethality during Murine Schistosomiasis. American Journal Of Pathology. 169(5). 1701–1712. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact